Coherus Bio (NQ: CHRS )
1.260
-0.290
(-18.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
All News about Coherus Bio![]() ![]() ![]() ![]()
Recap: Coherus BioSciences Q4 Earnings
March 13, 2024
Via Benzinga
![]()
Earnings Preview For Coherus BioSciences
March 12, 2024
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Coherus Completes Divestiture of Ophthalmology Franchise
March 04, 2024
Via GlobeNewswire
![]()
Coherus BioSciences Announces New Employment Inducement Grants
February 23, 2024
Via GlobeNewswire
![]() ![]() ![]()
Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP
February 05, 2024
Via GlobeNewswire
![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Penticton Herald
Phone number: 250-492-4002
E-mail: csr@ok.bc.ca
Address: 186 Nanaimo Ave. W.
Penticton, BC V2A 1N4
© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.